Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial
Clinical Infectious Diseases (2023) - Comments
pubmed: 35762834  doi: 10.1093/cid/ciac523  issn: 1058-4838  issn: 1537-6591 

Anthony Raymond Tam, Ricky Ruiqi Zhang, Kwok-Cheung Lung, Raymond Liu, Ka-Yi Leung, Danlei Liu, Yujing Fan, Lu Lu, Athene Hoi-Ying Lam, Tom Wai-Hin Chung, Cyril Chik-Yan Yip, Jenny Lo, Alan Ka-Lun Wu, Rodney Lee, Simon Sin, Pauline Yeung Ng, Wai-Ming Chan, Hoi-Ping Shum, Wing-Wa Yan, Jasper Fuk-Woo Chan